liver disease
Conditions
Interventions
ALSS group:NA
Sponsors
The Second Hospital of Nanjing
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with liver failure diagnosed with reference to the Asia-Pacific Liver Failure and the Chinese Medical Association Liver Failure Diagnostic and Treatment Guidelines, norms, etc.; over 18 years of age, less than 70 years of age; progressive deepening of jaundice (TBIL = 171 µmol/L or daily rise of = 17.1 µmol/L); hospitalized, with indications for artificial liver therapy, and proposed to carry out artificial liver therapy patients.
Exclusion criteria
Exclusion criteria: Maternity; end-stage liver disease or liver failure combined with non-hepatic secondary failure of extrahepatic organs; uncontrolled acute bleeding; established irreversible infections; intestinal dysfunction GIF scores greater than 2 Patients not scheduled for DPMAS therapy alone or in combination with plasma exchange with irregularities in their primary drug therapy. Participation in this study was deemed unsuitable in the judgment of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AIC/BIC;AUC;Model calibration evaluation;Evaluation of model clinical applicability; | — |
Countries
China
Contacts
Public ContactYishan Zheng
The Second Hospital of Nanjing
Outcome results
None listed